关注
Asis Palazon
Asis Palazon
Principal Investigator, CICbiogune
在 cicbiogune.es 的电子邮件经过验证
标题
引用次数
引用次数
年份
HIF transcription factors, inflammation, and immunity
A Palazon, AW Goldrath, V Nizet, RS Johnson
Immunity 41 (4), 518-528, 2014
11162014
An HIF-1α/VEGF-A axis in cytotoxic T cells regulates tumor progression
A Palazon, PA Tyrakis, D Macias, P Veliça, H Rundqvist, S Fitzpatrick, ...
Cancer cell 32 (5), 669-683. e5, 2017
4202017
S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate
PA Tyrakis, A Palazon, D Macias, KL Lee, AT Phan, P Veliça, J You, ...
Nature 540 (7632), 236-241, 2016
3632016
CAR-T cells hit the tumor microenvironment: strategies to overcome tumor escape
A Rodriguez-Garcia, A Palazon, E Noguera-Ortega, DJ Powell Jr, ...
Frontiers in immunology 11, 1109, 2020
2192020
Molecular pathways: hypoxia response in immune cells fighting or promoting cancer
A Palazón, J Aragonés, A Morales-Kastresana, MO de Landázuri, ...
Clinical Cancer Research 18 (5), 1207-1213, 2012
2192012
Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes
C Alfaro, N Suarez, A Gonzalez, S Solano, L Erro, J Dubrot, A Palazon, ...
British journal of cancer 100 (7), 1111-1119, 2009
2192009
Constitutive glycolytic metabolism supports CD8+ T cell effector memory differentiation during viral infection
AT Phan, AL Doedens, A Palazon, PA Tyrakis, KP Cheung, RS Johnson, ...
Immunity 45 (5), 1024-1037, 2016
2022016
The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy
A Palazón, I Martínez-Forero, A Teijeira, A Morales-Kastresana, C Alfaro, ...
Cancer discovery 2 (7), 608-623, 2012
1902012
Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes
A Palazón, A Teijeira, I Martínez-Forero, S Hervás-Stubbs, C Roncal, ...
Cancer research 71 (3), 801-811, 2011
1792011
Treatment with anti-CD137 mAbs causes intense accumulations of liver T cells without selective antitumor immunotherapeutic effects in this organ
J Dubrot, F Milheiro, C Alfaro, A Palazón, I Martinez-Forero, ...
Cancer Immunology, Immunotherapy 59, 1223-1233, 2010
1792010
SARS-CoV-2 infection dysregulates the metabolomic and lipidomic profiles of serum
C Bruzzone, M Bizkarguenaga, R Gil-Redondo, T Diercks, E Arana, ...
Iscience 23 (10), 2020
1552020
Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model
A Morales-Kastresana, MF Sanmamed, I Rodriguez, A Palazon, ...
Clinical Cancer Research 19 (22), 6151-6162, 2013
1532013
Immune response regulation in the tumor microenvironment by hypoxia
S Labiano, A Palazon, I Melero
Seminars in oncology 42 (3), 378-386, 2015
1432015
Design and Efficacy of a Monovalent Bispecific PD-1/CTLA4 Antibody That Enhances CTLA4 Blockade on PD-1+ Activated T Cells
SJ Dovedi, MJ Elder, C Yang, SI Sitnikova, L Irving, A Hansen, J Hair, ...
Cancer Discovery 11 (5), 1100-1117, 2021
1172021
Therapeutic antitumor efficacy of anti-CD137 agonistic monoclonal antibody in mouse models of myeloma
O Murillo, A Arina, S Hervas-Stubbs, A Gupta, B McCluskey, J Dubrot, ...
Clinical Cancer Research 14 (21), 6895-6906, 2008
982008
Effects of IFN‐α as a signal‐3 cytokine on human naïve and antigen‐experienced CD8+ T cells
S Hervas‐Stubbs, JI Riezu‐Boj, I Gonzalez, U Mancheño, J Dubrot, ...
European journal of immunology 40 (12), 3389-3402, 2010
932010
Structural characterization of N‐linked glycans in the receptor binding domain of the SARS‐CoV‐2 spike protein and their interactions with human lectins
MP Lenza, I Oyenarte, T Diercks, JI Quintana, A Gimeno, H Coelho, ...
Angewandte Chemie 132 (52), 23971-23979, 2020
902020
Dendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN‐α
A Rouzaut, S Garasa, Á Teijeira, I González, I Martinez‐Forero, N Suarez, ...
European journal of immunology 40 (11), 3054-3063, 2010
882010
In vivo depletion of DC impairs the anti‐tumor effect of agonistic anti‐CD137 mAb
O Murillo, J Dubrot, A Palazon, A Arina, A Azpilikueta, C Alfaro, S Solano, ...
European journal of immunology 39 (9), 2424-2436, 2009
842009
The factor inhibiting HIF asparaginyl hydroxylase regulates oxidative metabolism and accelerates metabolic adaptation to hypoxia
J Sim, AS Cowburn, A Palazon, B Madhu, PA Tyrakis, D Macías, ...
Cell metabolism 27 (4), 898-913. e7, 2018
772018
系统目前无法执行此操作,请稍后再试。
文章 1–20